Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ACER

Acer Therapeutics (ACER) Stock Price, News & Analysis

Acer Therapeutics logo

About Acer Therapeutics Stock (NASDAQ:ACER)

Advanced Chart

Key Stats

Today's Range
$0.66
$0.85
50-Day Range
$0.66
$0.90
52-Week Range
$0.55
$4.56
Volume
574,675 shs
Average Volume
N/A
Market Capitalization
$16.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ACER Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acer Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ACER Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Anumana Appoints Harry S. Palmin as CFO
See More Headlines

ACER Stock Analysis - Frequently Asked Questions

Acer Therapeutics Inc. (NASDAQ:ACER) released its quarterly earnings data on Friday, November, 19th. The biopharmaceutical company reported ($0.23) earnings per share for the quarter, beating the consensus estimate of ($0.28) by $0.05.

Acer Therapeutics subsidiaries include these companies: Opexa Therapeutics Inc..

Based on aggregate information from My MarketBeat watchlists, some other companies that Acer Therapeutics investors own include NVIDIA (NVDA), Broadcom (AVGO), CymaBay Therapeutics (CBAY), GE Aerospace (GE), Meta Platforms (META), Adobe (ADBE) and Novo Nordisk A/S (NVO).

Company Calendar

Last Earnings
11/19/2021
Today
7/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ACER
CIK
1069308
Employees
30
Year Founded
2013

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
24,460,000
Free Float
19,522,000
Market Cap
$16.15 million
Optionable
Not Optionable
Beta
N/A

Social Links

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:ACER) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners